ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ALNY Alnylam Pharmaceuticals Inc

143,31
-0,40 (-0,28%)
26 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Alnylam Pharmaceuticals Inc ALNY NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,40 -0,28% 143,31 23:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
144,08 143,00 146,065 143,31 143,71
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202414:00BWAlnylam to Webcast Conference Call Discussing First Quarter..
07.4.202414:00BWAlnylam Presents Positive Results from the KARDIA-2 Phase 2..
20.3.202413:00BWAlnylam to Webcast Investor Event to Discuss Results from..
13.3.202412:30BWAlnylam Launches Hereditary ATTR (hATTR) Amyloidosis..
06.3.202412:50BWAlnylam meldet positive KARDIA-2 Topline-Studienergebnisse,..
05.3.202423:39BWAlnylam annonce des résultats positifs de l’étude KARDIA-2..
05.3.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202413:30BWAlnylam Reports Positive KARDIA-2 Topline Study Results..
04.3.202422:33EDGAR2Form 8-K - Current report
29.2.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:00EDGAR2Form 144 - Report of proposed sale of securities
27.2.202414:30BWAlnylam to Webcast Presentations at Upcoming March Investor..
20.2.202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15.2.202414:10EDGAR2Form 8-K - Current report
15.2.202414:00BWAlnylam Pharmaceuticals Reports Fourth Quarter and Full Year..
10.2.202400:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202414:00BWAlnylam to Webcast Conference Call Discussing Fourth Quarter..
19.1.202422:31EDGAR2Form 8-K - Current report
09.1.202414:05BWAlnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year..
08.1.202413:00EDGAR2Form 8-K - Current report
08.1.202400:00BWAlnylam Announces Preliminary* Fourth Quarter and Full Year..
02.1.202413:30BWAlnylam to Webcast Presentation at 42nd Annual J.P. Morgan..
29.12.202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202322:03EDGAR2Form 144 - Report of proposed sale of securities
13.12.202313:30BWAlnylam Highlights Significant Progress with Platform..
11.12.202322:07EDGAR2Form 144 - Report of proposed sale of securities
06.12.202314:00BWAlnylam to Webcast Virtual R&D Day
30.11.202314:00BWAlnylam Ranks #1 on Boston Globe’s Top Places to Work List..
12.11.202318:08BWAlnylam présente des résultats positifs de l'étude KARDIA-1..
11.11.202322:00BWAlnylam Presents Positive Results from the KARDIA-1 Phase 2..
07.11.202314:00BWAlnylam to Webcast Presentations at Upcoming November..
02.11.202313:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202313:10EDGAR2Form 8-K - Current report
02.11.202313:00BWAlnylam Pharmaceuticals Reports Third Quarter 2023 Financial..
26.10.202320:00BWAlnylam Recognized by Science Magazine as Top Employer for..
25.10.202323:19BWAlnylam Announces Publication of Results from APOLLO-B Phase..
25.10.202317:05BWAlnylam Reports Additional Positive Interim Phase 1 Results..
19.10.202314:00BWAlnylam to Webcast Conference Call Discussing Third Quarter..
10.10.202313:30EDGAR2Form 8-K - Current report
10.10.202313:02IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations

Kürzlich von Ihnen besucht

Delayed Upgrade Clock